Tasca Therapeutics
Biotechnology Research
Cambridge, Massachusetts, United States
11 employees
- Employees
- 11
- Contacts
- 4
- Emails
- 4
- Phones
- 3
Tasca Therapeutics Overview
- Headquarters
- Cambridge, Massachusetts, United States
- Website
- www.tascatx.com
- Industry
- Biotechnology Research
- Employees
- 11
- Founded
- 2021
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Tasca Therapeutics
By harnessing the power of mass spectrometry-based proteomics to identify cancer-causing proteins that undergo a specific post-translational modification called auto-palmitoylation, Tasca is uniquely positioned to utilize previously unknown binding pockets to develop novel therapies for difficult-to-treat cancers. Tasca’s lead program, CP-383, is being developed to treat patients with tumors harboring a specific genetic profile and is expected to enter clinical trials in 2025.
Tasca Therapeutics Contact Details
- People in AeroLeads
- 4
- With contact data
- 4
- Email contacts
- 4
- 100.0% coverage
- Phone contacts
- 3
- 75.0% coverage
Tasca Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| John Flanagan | Tasca Therapeutics | Greater Boston, United States |
Email
|
| Valerie Malyvanh Jansen | Physician-scientist - Chief Medical | Cambridge, Massachusetts, United States |
Email
Phone
|
| Debjani Pal | Biologist I Driving Drug Discovery | Cambridge, Massachusetts, United States |
Email
Phone
|
| Nicholas Willis | Principal Scientist at Tasca | Greater Boston, United States |
Email
Phone
|
Employees by Management Level
Individual contributor
2 profiles
Executive
1 profile
Senior / Lead
1 profile
Tasca Therapeutics Tech Stack
Data / AI
2 profiles
Compare Similar Companies to Tasca Therapeutics
Kymera Therapeutics
Biotechnology Research
TRIANA Biomedicines
Biotechnology Research
EpiVax, Inc.
Biotechnology Research
Stylus Medicine
Biotechnology Research
Light Horse Therapeutics
Biotechnology Research
Photys Therapeutics
Biotechnology
Hyku Biosciences
Biotechnology Research
Cure Ventures
Venture Capital And Private Equity Principals
Synolo Therapeutics
Biotechnology Research
VerImmune
Biotechnology